6ix — Find Your Next Investment

Discover investor relations events, company profiles, and opportunities on 6ix. Connect with public companies and attend live investor events.

Please enable JavaScript to use all features of 6ix.com.

Oorspronkelijke tekst

Deze vertaling beoordelen

Je feedback wordt gebruikt om Google Translate te verbeteren

Latest Press Releases

Time	Headline
5m ago	Hovnanian Enterprises Reports Fiscal 2026 Second Quarter Results
6m ago	LivaNova Appoints Stefano Folli to Lead its Cardiopulmonary Business Unit
6m ago	KKR Sells CIRCOR Aerospace to Parker Hannifin for $2.55 Billion
6m ago	Cosmos Health Reports Q1 2026 Results: Revenue Up 31% to $17.9M, New Q1 Record; Total Liabilities Reduced by $4.5M; Stockholders' Equity Up 7.6%; Cash of $2.2M; Record Momentum Continues into Q2 with U.S. Expansion Underway
7m ago	Intuitive Announces Innovations to Advance Quintuple Aim

About

111.74USD+3.22 +2.97%

Closed • Updated at 13:22 GMT+00:00

Market Cap$6.30B

P/E Ratio123.01

Volume1.18M

Beta1.56

RSI45.01

Gross Margin47.85%

Health TechnologyPharmaceuticals: Major

Repligen Corporation — investor relations, events, news, and company updates on 6ix.

Latest News

Repligen Announces Publication of the Company’s 2025 Corporate Sustainability Report

Repligen Corporation to Present at Bank of America Securities 2026 Global Healthcare Conference

Repligen Reports First Quarter 2026 Financial Results and Updates Full Year 2026 Financial Guidance

Repligen to Report First Quarter 2026 Financial Results

908 Devices Appoints Kola Otitoju as Chief Business & Strategy Officer and Announces an Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Community Chat

Ask AI